FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965424079> ?p ?o ?g. }

• W1965424079 endingPage "99" @default.
• W1965424079 startingPage "92" @default.
• W1965424079 abstract "An investigational tetravalent vaccine combining pre-pandemic, MF59®-adjuvanted A/H5N1 vaccine with non-adjuvanted, trivalent, seasonal influenza vaccine has been developed, which has the potential to be used for pre-pandemic priming and to improve levels of compliance and coverage. It is important to determine whether the safety and immunogenicity of the combination vaccine is equivalent to that of the two separate vaccines when administered concomitantly. Healthy adults (n=601) were randomly assigned to three vaccination groups to receive either: (1) tetravalent vaccine and placebo concomitantly (in separate arms) on Day 1, followed by A/H5N1 vaccine on Day 22; (2) A/H5N1 vaccine and placebo concomitantly on Day 1, followed by tetravalent vaccine on Day 22; or (3) A/H5N1 and seasonal vaccines concomitantly on Day 1, followed by A/H5N1 vaccine on Day 22. Antibody responses were measured using single radial hemolysis (SRH), haemagglutination inhibition (HI), and microneutralization (MN) assays on Days 1, 22, and 43. Solicited adverse reactions were recorded for seven days after vaccination. Spontaneous adverse events were recorded throughout the study. The tetravalent vaccine elicited antibody titers equivalent to those for separate A/H5N1 and seasonal vaccines, and sufficient to meet the European licensure criteria against A/H5N1 and all three seasonal strains. Local and systemic reactions were mainly mild to moderate. No vaccine-related serious adverse events occurred. These findings demonstrate that MF59-adjuvanted A/H5N1 and seasonal influenza vaccines had an acceptable safety profile and could be effectively administered as a tetravalent formulation, supporting the possibility of integrating pre-pandemic priming into seasonal influenza vaccination programs." @default.
• W1965424079 created "2016-06-24" @default.
• W1965424079 creator A5003663640 @default.
• W1965424079 creator A5008146631 @default.
• W1965424079 creator A5012683569 @default.
• W1965424079 creator A5028639000 @default.
• W1965424079 creator A5040106253 @default.
• W1965424079 creator A5059793473 @default.
• W1965424079 creator A5063861111 @default.
• W1965424079 creator A5080603404 @default.
• W1965424079 date "2013-09-20" @default.
• W1965424079 modified "2023-10-18" @default.
• W1965424079 title "A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59^®" @default.
• W1965424079 cites W1519218675 @default.
• W1965424079 cites W1976093111 @default.
• W1965424079 cites W1986317774 @default.
• W1965424079 cites W1986534116 @default.
• W1965424079 cites W1992439635 @default.
• W1965424079 cites W2011879952 @default.
• W1965424079 cites W2013222068 @default.
• W1965424079 cites W2036596307 @default.
• W1965424079 cites W2048092342 @default.
• W1965424079 cites W2054135380 @default.
• W1965424079 cites W2057647944 @default.
• W1965424079 cites W2065069831 @default.
• W1965424079 cites W2070003896 @default.
• W1965424079 cites W2075710631 @default.
• W1965424079 cites W2087508560 @default.
• W1965424079 cites W2093051020 @default.
• W1965424079 cites W2095721550 @default.
• W1965424079 cites W2111360869 @default.
• W1965424079 cites W2115204343 @default.
• W1965424079 cites W2118362676 @default.
• W1965424079 cites W2131170401 @default.
• W1965424079 cites W2136931342 @default.
• W1965424079 cites W2152313594 @default.
• W1965424079 cites W2158112812 @default.
• W1965424079 cites W2314523976 @default.
• W1965424079 cites W2508794604 @default.
• W1965424079 doi "https://doi.org/10.4161/hv.26495" @default.
• W1965424079 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4181038" @default.
• W1965424079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24047817" @default.
• W1965424079 hasPublicationYear "2013" @default.
• W1965424079 type Work @default.
• W1965424079 sameAs 1965424079 @default.
• W1965424079 citedByCount "6" @default.
• W1965424079 countsByYear W19654240792014 @default.
• W1965424079 countsByYear W19654240792017 @default.
• W1965424079 countsByYear W19654240792020 @default.
• W1965424079 countsByYear W19654240792022 @default.
• W1965424079 crossrefType "journal-article" @default.
• W1965424079 hasAuthorship W1965424079A5003663640 @default.
• W1965424079 hasAuthorship W1965424079A5008146631 @default.
• W1965424079 hasAuthorship W1965424079A5012683569 @default.
• W1965424079 hasAuthorship W1965424079A5028639000 @default.
• W1965424079 hasAuthorship W1965424079A5040106253 @default.
• W1965424079 hasAuthorship W1965424079A5059793473 @default.
• W1965424079 hasAuthorship W1965424079A5063861111 @default.
• W1965424079 hasAuthorship W1965424079A5080603404 @default.
• W1965424079 hasBestOaLocation W19654240791 @default.
• W1965424079 hasConcept C126322002 @default.
• W1965424079 hasConcept C133239900 @default.
• W1965424079 hasConcept C142724271 @default.
• W1965424079 hasConcept C159047783 @default.
• W1965424079 hasConcept C159654299 @default.
• W1965424079 hasConcept C197934379 @default.
• W1965424079 hasConcept C203014093 @default.
• W1965424079 hasConcept C204787440 @default.
• W1965424079 hasConcept C22070199 @default.
• W1965424079 hasConcept C2522874641 @default.
• W1965424079 hasConcept C27081682 @default.
• W1965424079 hasConcept C2779134260 @default.
• W1965424079 hasConcept C2780689484 @default.
• W1965424079 hasConcept C2780868878 @default.
• W1965424079 hasConcept C2909469553 @default.
• W1965424079 hasConcept C3008058167 @default.
• W1965424079 hasConcept C3018751465 @default.
• W1965424079 hasConcept C32611913 @default.
• W1965424079 hasConcept C519248777 @default.
• W1965424079 hasConcept C524204448 @default.
• W1965424079 hasConcept C71924100 @default.
• W1965424079 hasConceptScore W1965424079C126322002 @default.
• W1965424079 hasConceptScore W1965424079C133239900 @default.
• W1965424079 hasConceptScore W1965424079C142724271 @default.
• W1965424079 hasConceptScore W1965424079C159047783 @default.
• W1965424079 hasConceptScore W1965424079C159654299 @default.
• W1965424079 hasConceptScore W1965424079C197934379 @default.
• W1965424079 hasConceptScore W1965424079C203014093 @default.
• W1965424079 hasConceptScore W1965424079C204787440 @default.
• W1965424079 hasConceptScore W1965424079C22070199 @default.
• W1965424079 hasConceptScore W1965424079C2522874641 @default.
• W1965424079 hasConceptScore W1965424079C27081682 @default.
• W1965424079 hasConceptScore W1965424079C2779134260 @default.
• W1965424079 hasConceptScore W1965424079C2780689484 @default.
• W1965424079 hasConceptScore W1965424079C2780868878 @default.
• W1965424079 hasConceptScore W1965424079C2909469553 @default.
• W1965424079 hasConceptScore W1965424079C3008058167 @default.
• W1965424079 hasConceptScore W1965424079C3018751465 @default.

• next